http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01153629-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccafce13eb770568b261a9cac7d3dd17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27176f5bbbfd702de498d84df8ff3ae5
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
filingDate 1987-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25da42b075b0cd1afad54f65eb39cf6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c2b92570aae1f34176da7d1ae3a9581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e275357f7b37cc9814ae8b67e238ae5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2cfe3568d34ddb4c31bdabb0e7b0ad8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_114afbb90f02c25203ab9e03a43235e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8861cccecf5fab2913bd316991ddfa7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72501a6a0baed3ebac37ac397e95030c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85ae12ebeb6094bc6f082dd431ffad45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2885a6057e26a9a549642eac46b3e0b6
publicationDate 1989-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H01153629-A
titleOfInvention Anticancer agent
abstract PURPOSE: To obtain an anticancer agent containing a compound selected from a group consisting of docosahexaenoic acid and ester thereof as an active ingredient, almost free from side effects and exhibiting effects for preventing propagation of cancer cell after operation and preventing metastasis thereof and orally administrable. n CONSTITUTION: One or two or more kind of compounds selected from a group consisting of docosahexaenoic acid and ester thereof are contained as an active ingredient. In use thereof these compounds are used in mixed form with other fatty acid and/or ester thereof and contains preferably ≥25wt.% doco sahexaenoic acid. As the docosahexaenoic acid which is an active ingredient, e.g. oils and fats having 25W30wt.% active ingredient compound content and obtained by purifying a fish oil of tuna, skipjack, etc., according to an ordinary method and then wintering the purified oil to remove saturated triglyceride or fatty acid mixture containing 70W90wt.% triglyceride obtained by subjecting the above-mentioned fish oil to alkali hydrolysis and purifying and distilling the resultant fish oil fatty acid is used. n COPYRIGHT: (C)1989,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8314077-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5919815-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7235583-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6602902-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6277319-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0686377-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04295423-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6080877-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006518358-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7816398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006517954-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05331105-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5994392-A
priorityDate 1987-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411029818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175542
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID411573
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID411573

Total number of triples: 42.